个人中心 - 老虎社区

3088b857

IP属地：未知

帖子 · 19帖子 · 19
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- 3088b8573088b857
  ·2021-07-13
  Like
  非常抱歉，此主贴已删除
  2,530 评论
  1
  分享
  举报
- 3088b8573088b857
  ·2021-06-22
  Oh
  非常抱歉，此主贴已删除
  2,239 评论
  1
  分享
  举报
- 3088b8573088b857
  ·2021-06-21
  Nice
  Orphazyme rose more than 6% in premarket trading<blockquote>Orphazyme 在盘前交易中上涨超过 6%</blockquote>
  (June 21) Orphazyme rose more than 6% in premarket trading. What happened Shares of Orphazyme, a c
  Orphazyme rose more than 6% in premarket trading<blockquote>Orphazyme 在盘前交易中上涨超过 6%</blockquote>
  2,731 评论
  1
  分享
  举报
- 3088b8573088b857
  ·2021-06-21
  Ok
  非常抱歉，此主贴已删除
  2,255 评论
  3
  分享
  举报
- 3088b8573088b857
  ·2021-06-19
  Like
  非常抱歉，此主贴已删除
  3,733 评论
  1
  分享
  举报
- 3088b8573088b857
  ·2021-06-18
  [Doubt]
  非常抱歉，此主贴已删除
  2,847 评论
  1
  分享
  举报
- 3088b8573088b857
  ·2021-06-18
  [Lovely]
  非常抱歉，此主贴已删除
  2,984 评论
  点赞
  分享
  举报
- 3088b8573088b857
  ·2021-06-18
  Tell me your opinion about this news...
  非常抱歉，此主贴已删除
  2,178 评论
  点赞
  分享
  举报
- 3088b8573088b857
  ·2021-06-18
  [Strong]
  非常抱歉，此主贴已删除
  3,127 评论
  点赞
  分享
  举报
- 3088b8573088b857
  ·2021-06-18
  [Smile] [Smile]
  Ford Lifts Profit Guidance While F-150 Lightning, New Vehicles See Strong Demand<blockquote>福特上调利润指引，而 F-150 Lightning、新车需求强劲</blockquote>
  Ford joined GM with upbeat earnings guidance and sees strong reservations for critical new vehicles including its first electric truck.
  Ford Lifts Profit Guidance While F-150 Lightning, New Vehicles See Strong Demand<blockquote>福特上调利润指引，而 F-150 Lightning、新车需求强劲</blockquote>
  2,570 评论
  点赞
  分享
  举报

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3566691395182663","uuid":"3566691395182663","gmtCreate":1603597371989,"gmtModify":1623853851282,"name":"3088b857","pinyin":"charlotte26","introduction":"","introductionEn":"","signature":"","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":8,"tweetSize":19,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.04.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.08.11","exceedPercentage":"60.64%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":142822709,"gmtCreate":1626141928501,"gmtModify":1633929709721,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566691395182663","authorIdStr":"3566691395182663"},"themes":[],"title":"","htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/142822709","repostId":"1175534160","repostType":4,"isVote":1,"tweetType":1,"viewCount":2530,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120449218,"gmtCreate":1624334394634,"gmtModify":1634007615116,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566691395182663","authorIdStr":"3566691395182663"},"themes":[],"title":"","htmlText":"Oh","listText":"Oh","text":"Oh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/120449218","repostId":"1191349655","repostType":4,"isVote":1,"tweetType":1,"viewCount":2239,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":167677108,"gmtCreate":1624268018504,"gmtModify":1634008661767,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566691395182663","authorIdStr":"3566691395182663"},"themes":[],"title":"","htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/167677108","repostId":"1184501396","repostType":4,"repost":{"id":"1184501396","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624267024,"share":"https://www.laohunote.com/m/news/1184501396?lang=zh_CN&edition=full","pubTime":"2021-06-21 17:17","market":"us","language":"en","title":"Orphazyme rose more than 6% in premarket trading<blockquote>Orphazyme 在盘前交易中上涨超过 6%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1184501396","media":"Tiger Newspress","summary":"(June 21) Orphazyme rose more than 6% in premarket trading. \n\nWhat happened\nShares of Orphazyme, a c","content":"<p>(June 21)&nbsp;Orphazyme rose more than 6% in premarket trading.&nbsp;</p><p><blockquote>（6月21日）Orphazyme在盘前交易中上涨超过6%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/a1e2eb27cc68ce74ddd21a64a64634cf\" tg-width=\"719\" tg-height=\"495\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <b>What happened</b></p><p><blockquote><b>发生了什么事</b></blockquote></p><p> Shares of&nbsp;<b>Orphazyme</b>, a clinical-stage biopharmaceutical company, got hammered after the Food and Drug Administration (FDA) refused to approve an application for the company's lead candidate. Investors are now uncertain when the biotech could have an approved product to sell, and pushed the stock 44.4% lower as of 12:12 p.m. EDT on last&nbsp;Friday.</p><p><blockquote>股份<b>奥尔法酶</b>在美国食品药品监督管理局 (FDA) 拒绝批准该公司主要候选人的申请后，一家临床阶段的生物制药公司受到了打击。投资者现在不确定这家生物技术公司何时可以销售获得批准的产品，截至美国东部时间中午 12:12，该股下跌 44.4%。上周五美国东部时间。</blockquote></p><p> <b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p> The FDA began reviewing an application for Orphazyme's lead candidate arimoclomol last September as a potential treatment for a rare but life-threatening disease called Neimann-Pick Disease Type-C (NPC). Earlier this month, shares of Orphazymeshot upmore than 200% in anticipation of a green light that never came.</p><p><blockquote>FDA 去年 9 月开始审查 Orphazyme 的主要候选药物 arimoclomol 的申请，作为一种罕见但危及生命的疾病的潜在治疗方法，称为 Neimann-Pick 病 C 型 (NPC)。本月早些时候，Orphazyme 的股价上涨了 200% 以上，原因是预期从未到来的绿灯。</blockquote></p><p> Instead of an approval decision for arimoclomol, the agency asked for more information in the form of a complete response letter (CRL). That came as a shock to heaps of investors who were new to the complex world of drug development and were expecting a massiveshort squeeze.</p><p><blockquote>该机构没有做出arimoclomol的批准决定，而是以完整回复函（CRL）的形式要求提供更多信息。这让许多投资者感到震惊，他们刚刚接触复杂的药物开发世界，并预计会出现大规模的空头挤压。</blockquote></p><p> Many institutional investors were betting against Orphazyme because its lead candidate failed to achieve the primary endpoint in the pivotal study underpinning the application. Arimoclomol also failed to improve patients' scores on a secondary endpoint specifically requested by the FDA.</p><p><blockquote>许多机构投资者押注 Orphazyme，因为其主要候选药物未能在支撑该申请的关键研究中实现主要终点。Arimoclomol 也未能改善 FDA 特别要求的次要终点的患者评分。</blockquote></p><p> <b>Now what</b></p><p><blockquote><b>现在呢</b></blockquote></p><p> According to Orphazyme, the company needs to further substantiate the validity of the primary endpoint that arimoclomol almost achieved. To satisfy the FDA, the company will most likely have to run a new pivotal study.</p><p><blockquote>据Orphazyme称，该公司需要进一步证实arimoclomol几乎达到的主要终点的有效性。为了满足 FDA 的要求，该公司很可能不得不进行一项新的关键研究。</blockquote></p><p> Some shareholders remain hopeful that the European Medicines Agency will be less strict than the FDA. While the FDA's European colleague has been more lenient regarding treatments for rare diseases in the past, arimoclomol probably isn't moving forward until it produces some convincing clinical-trial results.</p><p><blockquote>一些股东仍然希望欧洲药品管理局不会像FDA那样严格。虽然FDA的欧洲同事过去在罕见疾病的治疗方面更加宽松，但arimoclomol可能不会向前推进，直到它产生一些令人信服的临床试验结果。</blockquote></p><p> Despite lacking a clear path forward, the Denmark-headquartered company still boasts a fairly large market cap in excess of $500 million at recent prices. Irrational expectations could keep it elevated, but this is way too high for anyclinical-stage biotechin Orphazyme's position.</p><p><blockquote>尽管缺乏明确的前进道路，这家总部位于丹麦的公司仍然拥有相当大的市值，按最近的价格计算，超过 5 亿美元。非理性的期望可能会使其保持较高水平，但对于任何临床阶段的生物技术公司 Orphazyme 的地位来说，这都太高了。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Orphazyme rose more than 6% in premarket trading<blockquote>Orphazyme 在盘前交易中上涨超过 6%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOrphazyme rose more than 6% in premarket trading<blockquote>Orphazyme 在盘前交易中上涨超过 6%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-06-21 17:17</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>(June 21)&nbsp;Orphazyme rose more than 6% in premarket trading.&nbsp;</p><p><blockquote>（6月21日）Orphazyme在盘前交易中上涨超过6%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/a1e2eb27cc68ce74ddd21a64a64634cf\" tg-width=\"719\" tg-height=\"495\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <b>What happened</b></p><p><blockquote><b>发生了什么事</b></blockquote></p><p> Shares of&nbsp;<b>Orphazyme</b>, a clinical-stage biopharmaceutical company, got hammered after the Food and Drug Administration (FDA) refused to approve an application for the company's lead candidate. Investors are now uncertain when the biotech could have an approved product to sell, and pushed the stock 44.4% lower as of 12:12 p.m. EDT on last&nbsp;Friday.</p><p><blockquote>股份<b>奥尔法酶</b>在美国食品药品监督管理局 (FDA) 拒绝批准该公司主要候选人的申请后，一家临床阶段的生物制药公司受到了打击。投资者现在不确定这家生物技术公司何时可以销售获得批准的产品，截至美国东部时间中午 12:12，该股下跌 44.4%。上周五美国东部时间。</blockquote></p><p> <b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p> The FDA began reviewing an application for Orphazyme's lead candidate arimoclomol last September as a potential treatment for a rare but life-threatening disease called Neimann-Pick Disease Type-C (NPC). Earlier this month, shares of Orphazymeshot upmore than 200% in anticipation of a green light that never came.</p><p><blockquote>FDA 去年 9 月开始审查 Orphazyme 的主要候选药物 arimoclomol 的申请，作为一种罕见但危及生命的疾病的潜在治疗方法，称为 Neimann-Pick 病 C 型 (NPC)。本月早些时候，Orphazyme 的股价上涨了 200% 以上，原因是预期从未到来的绿灯。</blockquote></p><p> Instead of an approval decision for arimoclomol, the agency asked for more information in the form of a complete response letter (CRL). That came as a shock to heaps of investors who were new to the complex world of drug development and were expecting a massiveshort squeeze.</p><p><blockquote>该机构没有做出arimoclomol的批准决定，而是以完整回复函（CRL）的形式要求提供更多信息。这让许多投资者感到震惊，他们刚刚接触复杂的药物开发世界，并预计会出现大规模的空头挤压。</blockquote></p><p> Many institutional investors were betting against Orphazyme because its lead candidate failed to achieve the primary endpoint in the pivotal study underpinning the application. Arimoclomol also failed to improve patients' scores on a secondary endpoint specifically requested by the FDA.</p><p><blockquote>许多机构投资者押注 Orphazyme，因为其主要候选药物未能在支撑该申请的关键研究中实现主要终点。Arimoclomol 也未能改善 FDA 特别要求的次要终点的患者评分。</blockquote></p><p> <b>Now what</b></p><p><blockquote><b>现在呢</b></blockquote></p><p> According to Orphazyme, the company needs to further substantiate the validity of the primary endpoint that arimoclomol almost achieved. To satisfy the FDA, the company will most likely have to run a new pivotal study.</p><p><blockquote>据Orphazyme称，该公司需要进一步证实arimoclomol几乎达到的主要终点的有效性。为了满足 FDA 的要求，该公司很可能不得不进行一项新的关键研究。</blockquote></p><p> Some shareholders remain hopeful that the European Medicines Agency will be less strict than the FDA. While the FDA's European colleague has been more lenient regarding treatments for rare diseases in the past, arimoclomol probably isn't moving forward until it produces some convincing clinical-trial results.</p><p><blockquote>一些股东仍然希望欧洲药品管理局不会像FDA那样严格。虽然FDA的欧洲同事过去在罕见疾病的治疗方面更加宽松，但arimoclomol可能不会向前推进，直到它产生一些令人信服的临床试验结果。</blockquote></p><p> Despite lacking a clear path forward, the Denmark-headquartered company still boasts a fairly large market cap in excess of $500 million at recent prices. Irrational expectations could keep it elevated, but this is way too high for anyclinical-stage biotechin Orphazyme's position.</p><p><blockquote>尽管缺乏明确的前进道路，这家总部位于丹麦的公司仍然拥有相当大的市值，按最近的价格计算，超过 5 亿美元。非理性的期望可能会使其保持较高水平，但对于任何临床阶段的生物技术公司 Orphazyme 的地位来说，这都太高了。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1184501396","content_text":"(June 21) Orphazyme rose more than 6% in premarket trading. \n\nWhat happened\nShares of Orphazyme, a clinical-stage biopharmaceutical company, got hammered after the Food and Drug Administration (FDA) refused to approve an application for the company's lead candidate. Investors are now uncertain when the biotech could have an approved product to sell, and pushed the stock 44.4% lower as of 12:12 p.m. EDT on last Friday.\nSo what\nThe FDA began reviewing an application for Orphazyme's lead candidate arimoclomol last September as a potential treatment for a rare but life-threatening disease called Neimann-Pick Disease Type-C (NPC). Earlier this month, shares of Orphazymeshot upmore than 200% in anticipation of a green light that never came.\nInstead of an approval decision for arimoclomol, the agency asked for more information in the form of a complete response letter (CRL). That came as a shock to heaps of investors who were new to the complex world of drug development and were expecting a massiveshort squeeze.\nMany institutional investors were betting against Orphazyme because its lead candidate failed to achieve the primary endpoint in the pivotal study underpinning the application. Arimoclomol also failed to improve patients' scores on a secondary endpoint specifically requested by the FDA.\nNow what\nAccording to Orphazyme, the company needs to further substantiate the validity of the primary endpoint that arimoclomol almost achieved. To satisfy the FDA, the company will most likely have to run a new pivotal study.\nSome shareholders remain hopeful that the European Medicines Agency will be less strict than the FDA. While the FDA's European colleague has been more lenient regarding treatments for rare diseases in the past, arimoclomol probably isn't moving forward until it produces some convincing clinical-trial results.\nDespite lacking a clear path forward, the Denmark-headquartered company still boasts a fairly large market cap in excess of $500 million at recent prices. Irrational expectations could keep it elevated, but this is way too high for anyclinical-stage biotechin Orphazyme's position.","news_type":1,"symbols_score_info":{"ORPH":0.9}},"isVote":1,"tweetType":1,"viewCount":2731,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":167674785,"gmtCreate":1624267997047,"gmtModify":1634008661990,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566691395182663","authorIdStr":"3566691395182663"},"themes":[],"title":"","htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/167674785","repostId":"1154249454","repostType":4,"isVote":1,"tweetType":1,"viewCount":2255,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":165091616,"gmtCreate":1624079232035,"gmtModify":1634010936496,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566691395182663","authorIdStr":"3566691395182663"},"themes":[],"title":"","htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/165091616","repostId":"2144034771","repostType":4,"isVote":1,"tweetType":1,"viewCount":3733,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166480199,"gmtCreate":1624022514011,"gmtModify":1634023995857,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566691395182663","authorIdStr":"3566691395182663"},"themes":[],"title":"","htmlText":"[Doubt]&nbsp;","listText":"[Doubt]&nbsp;","text":"[Doubt]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/166480199","repostId":"1164089282","repostType":4,"isVote":1,"tweetType":1,"viewCount":2847,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166417840,"gmtCreate":1624022494880,"gmtModify":1634023996561,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566691395182663","authorIdStr":"3566691395182663"},"themes":[],"title":"","htmlText":"[Lovely]&nbsp;","listText":"[Lovely]&nbsp;","text":"[Lovely]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/166417840","repostId":"1181667218","repostType":4,"isVote":1,"tweetType":1,"viewCount":2984,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168462546,"gmtCreate":1623981233985,"gmtModify":1634024788926,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566691395182663","authorIdStr":"3566691395182663"},"themes":[],"title":"","htmlText":"Tell me your opinion about this news...","listText":"Tell me your opinion about this news...","text":"Tell me your opinion about this news...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/168462546","repostId":"2144374909","repostType":4,"isVote":1,"tweetType":1,"viewCount":2178,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168462335,"gmtCreate":1623981219127,"gmtModify":1634024789411,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566691395182663","authorIdStr":"3566691395182663"},"themes":[],"title":"","htmlText":"[Strong]&nbsp;","listText":"[Strong]&nbsp;","text":"[Strong]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/168462335","repostId":"2144490227","repostType":4,"isVote":1,"tweetType":1,"viewCount":3127,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168528788,"gmtCreate":1623979040844,"gmtModify":1634024864907,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"3088b857","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566691395182663","authorIdStr":"3566691395182663"},"themes":[],"title":"","htmlText":"[Smile]&nbsp;[Smile]&nbsp;","listText":"[Smile]&nbsp;[Smile]&nbsp;","text":"[Smile] [Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/168528788","repostId":"2144742524","repostType":4,"repost":{"id":"2144742524","kind":"highlight","weMediaInfo":{"introduction":"The leading daily newsletter for the latest financial and business news. 33Yrs Helping Stock Investors with Investing Insights, Tools, News & More.","home_visible":0,"media_name":"Investors","id":"1085713068","head_image":"https://static.tigerbbs.com/608dd68a89ed486e18f64efe3136266c"},"pubTimestamp":1623942517,"share":"https://www.laohunote.com/m/news/2144742524?lang=zh_CN&edition=full","pubTime":"2021-06-17 23:08","market":"us","language":"en","title":"Ford Lifts Profit Guidance While F-150 Lightning, New Vehicles See Strong Demand<blockquote>福特上调利润指引，而 F-150 Lightning、新车需求强劲</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2144742524","media":"Investors","summary":"Ford joined GM with upbeat earnings guidance and sees strong reservations for critical new vehicles including its first electric truck.","content":"<p><b>Ford</b> joined <b>General Motors</b> with upbeat earnings guidance and sees strong reservations for critical new vehicles including its first electric truck. Ford stock rose.</p><p><blockquote><b>福特</b>加入<b>通用汽车</b>盈利指引乐观，并预计包括首款电动卡车在内的关键新车预订量强劲。福特股价上涨。</blockquote></p><p> The No. 2 U.S. auto giant said Thursday that it expects adjusted pretax earnings for the second quarter to surpass its own expectations and be \"significantly better\" than a year ago.</p><p><blockquote>这家美国第二大汽车巨头周四表示，预计第二季度调整后税前收益将超出自己的预期，并“明显好于”一年前。</blockquote></p><p> That's despite the semiconductor shortage, which Ford said April 28 would halve its planned Q2 production and reduce full-year adjusted EBIT to $5.5 billion-$6.5 billion.</p><p><blockquote>尽管存在半导体短缺，福特在 4 月 28 日表示，将把第二季度计划产量减半，并将全年调整后息税前利润减少至 55 亿至 65 亿美元。</blockquote></p><p> Ford did not offer specific Q2 guidance on April 28 or Thursday. It will report for Q2 and offer outlook for the rest of the year July 28.</p><p><blockquote>福特没有在4月28日或周四提供具体的第二季度指引。它将于 7 月 28 日发布第二季度报告并提供今年剩余时间的展望。</blockquote></p><p> On Wednesday, GM forecast adjusted earnings before taxes of $8.5 billion-$9.5 billion in the first half of 2021, up from an earlier view for $5.5 billion, due to strong demand for its SUVs and trucks. GM remains cautious for the full year.</p><p><blockquote>周三，由于对其 SUV 和卡车的强劲需求，通用汽车预测 2021 年上半年调整后税前利润为 85 亿至 95 亿美元，高于之前预测的 55 亿美元。通用汽车全年保持谨慎。</blockquote></p><p> Also Thursday, Ford touted 100,000 reservations for the F-150 Lightning, its first all-electric pickup truck and <b>Tesla</b> Cybertruck rival. That's up from 20,000 reported May 20 after a launch event, and 70,000 on May 26.</p><p><blockquote>同样在周四，福特公布了其首款全电动皮卡 F-150 Lightning 的 10 万份预订量。<b>特斯拉</b>赛博卡车竞争对手。这一数字高于 5 月 20 日发布会后报告的 20,000 人和 5 月 26 日报告的 70,000 人。</blockquote></p><p> Meanwhile, its new compact Maverick truck has 36,000 reservations, just a week after unveiling. Ford also reported 20,000 reservations for the all-electric E-Transit commercial van and 190,000 for the new, full-size Bronco SUV.</p><p><blockquote>与此同时，其新款紧凑型 Maverick 卡车在亮相仅一周后就获得了 36,000 份预订。福特还报告称，全电动 E-Transit 商用货车预订量为 20,000 辆，新款全尺寸 Bronco SUV 预订量为 190,000 辆。</blockquote></p><p> CEO Jim Farley will further address Q2 financial guidance at a Deutsche Bank auto industry conference Thursday afternoon.</p><p><blockquote>首席执行官吉姆·法利 (Jim Farley) 将在周四下午的德意志银行汽车行业会议上进一步阐述第二季度财务指引。</blockquote></p><p> <h2>Ford Stock</h2> Shares rose 1.3% to 15.22 in Thursday's stock market. Ford stock, on the IBD Leaderboard, is extended from a cup-without-handle 13.72 buy point, cleared late May on its bold EV shift. GM stock eased 1% to 61.07 as it eyes a 63.54 cup-shaped buy point.</p><p><blockquote><h2>福特股票</h2>周四股市上涨 1.3%，至 15.22 点。IBD 排行榜上的福特股票从 13.72 个买入点延长，该买入点在 5 月底因大胆转向电动汽车而被清除。通用汽车股价下跌 1%，至 61.07 点，预计杯形买入点为 63.54。</blockquote></p><p> On Wednesday, GM announced it will invest $35 billion to develop electric vehicles (EVs) and autonomous vehicles (AVs) through 2025. That's a 30% increase from its most recent forecast for $27 billion set last November, and a 75% increase from an initial forecast of $20 billion set in March 2020.</p><p><blockquote>周三，通用汽车宣布将在 2025 年前投资 350 亿美元开发电动汽车 (EV) 和自动驾驶汽车 (AV)。这比去年 11 月设定的 270 亿美元的最新预测增长了 30%，比 2020 年 3 月设定的 200 亿美元的初始预测增长了 75%。</blockquote></p><p> By comparison, Ford in May announced $30 billion on EV- AV spending through 2025, up from a prior view for $22 billion.</p><p><blockquote>相比之下，福特在 5 月份宣布，到 2025 年，电动汽车支出将达到 300 亿美元，高于之前的 220 亿美元。</blockquote></p><p> But Ford's investments include years prior to 2020, while GM's spending is for 2020 through 2025.</p><p><blockquote>但福特的投资包括 2020 年之前的几年，而通用汽车的支出涵盖 2020 年至 2025 年。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ford Lifts Profit Guidance While F-150 Lightning, New Vehicles See Strong Demand<blockquote>福特上调利润指引，而 F-150 Lightning、新车需求强劲</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFord Lifts Profit Guidance While F-150 Lightning, New Vehicles See Strong Demand<blockquote>福特上调利润指引，而 F-150 Lightning、新车需求强劲</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/608dd68a89ed486e18f64efe3136266c);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Investors </p>\n<p class=\"h-time smaller\">2021-06-17 23:08</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p><b>Ford</b> joined <b>General Motors</b> with upbeat earnings guidance and sees strong reservations for critical new vehicles including its first electric truck. Ford stock rose.</p><p><blockquote><b>福特</b>加入<b>通用汽车</b>盈利指引乐观，并预计包括首款电动卡车在内的关键新车预订量强劲。福特股价上涨。</blockquote></p><p> The No. 2 U.S. auto giant said Thursday that it expects adjusted pretax earnings for the second quarter to surpass its own expectations and be \"significantly better\" than a year ago.</p><p><blockquote>这家美国第二大汽车巨头周四表示，预计第二季度调整后税前收益将超出自己的预期，并“明显好于”一年前。</blockquote></p><p> That's despite the semiconductor shortage, which Ford said April 28 would halve its planned Q2 production and reduce full-year adjusted EBIT to $5.5 billion-$6.5 billion.</p><p><blockquote>尽管存在半导体短缺，福特在 4 月 28 日表示，将把第二季度计划产量减半，并将全年调整后息税前利润减少至 55 亿至 65 亿美元。</blockquote></p><p> Ford did not offer specific Q2 guidance on April 28 or Thursday. It will report for Q2 and offer outlook for the rest of the year July 28.</p><p><blockquote>福特没有在4月28日或周四提供具体的第二季度指引。它将于 7 月 28 日发布第二季度报告并提供今年剩余时间的展望。</blockquote></p><p> On Wednesday, GM forecast adjusted earnings before taxes of $8.5 billion-$9.5 billion in the first half of 2021, up from an earlier view for $5.5 billion, due to strong demand for its SUVs and trucks. GM remains cautious for the full year.</p><p><blockquote>周三，由于对其 SUV 和卡车的强劲需求，通用汽车预测 2021 年上半年调整后税前利润为 85 亿至 95 亿美元，高于之前预测的 55 亿美元。通用汽车全年保持谨慎。</blockquote></p><p> Also Thursday, Ford touted 100,000 reservations for the F-150 Lightning, its first all-electric pickup truck and <b>Tesla</b> Cybertruck rival. That's up from 20,000 reported May 20 after a launch event, and 70,000 on May 26.</p><p><blockquote>同样在周四，福特公布了其首款全电动皮卡 F-150 Lightning 的 10 万份预订量。<b>特斯拉</b>赛博卡车竞争对手。这一数字高于 5 月 20 日发布会后报告的 20,000 人和 5 月 26 日报告的 70,000 人。</blockquote></p><p> Meanwhile, its new compact Maverick truck has 36,000 reservations, just a week after unveiling. Ford also reported 20,000 reservations for the all-electric E-Transit commercial van and 190,000 for the new, full-size Bronco SUV.</p><p><blockquote>与此同时，其新款紧凑型 Maverick 卡车在亮相仅一周后就获得了 36,000 份预订。福特还报告称，全电动 E-Transit 商用货车预订量为 20,000 辆，新款全尺寸 Bronco SUV 预订量为 190,000 辆。</blockquote></p><p> CEO Jim Farley will further address Q2 financial guidance at a Deutsche Bank auto industry conference Thursday afternoon.</p><p><blockquote>首席执行官吉姆·法利 (Jim Farley) 将在周四下午的德意志银行汽车行业会议上进一步阐述第二季度财务指引。</blockquote></p><p> <h2>Ford Stock</h2> Shares rose 1.3% to 15.22 in Thursday's stock market. Ford stock, on the IBD Leaderboard, is extended from a cup-without-handle 13.72 buy point, cleared late May on its bold EV shift. GM stock eased 1% to 61.07 as it eyes a 63.54 cup-shaped buy point.</p><p><blockquote><h2>福特股票</h2>周四股市上涨 1.3%，至 15.22 点。IBD 排行榜上的福特股票从 13.72 个买入点延长，该买入点在 5 月底因大胆转向电动汽车而被清除。通用汽车股价下跌 1%，至 61.07 点，预计杯形买入点为 63.54。</blockquote></p><p> On Wednesday, GM announced it will invest $35 billion to develop electric vehicles (EVs) and autonomous vehicles (AVs) through 2025. That's a 30% increase from its most recent forecast for $27 billion set last November, and a 75% increase from an initial forecast of $20 billion set in March 2020.</p><p><blockquote>周三，通用汽车宣布将在 2025 年前投资 350 亿美元开发电动汽车 (EV) 和自动驾驶汽车 (AV)。这比去年 11 月设定的 270 亿美元的最新预测增长了 30%，比 2020 年 3 月设定的 200 亿美元的初始预测增长了 75%。</blockquote></p><p> By comparison, Ford in May announced $30 billion on EV- AV spending through 2025, up from a prior view for $22 billion.</p><p><blockquote>相比之下，福特在 5 月份宣布，到 2025 年，电动汽车支出将达到 300 亿美元，高于之前的 220 亿美元。</blockquote></p><p> But Ford's investments include years prior to 2020, while GM's spending is for 2020 through 2025.</p><p><blockquote>但福特的投资包括 2020 年之前的几年，而通用汽车的支出涵盖 2020 年至 2025 年。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GUID":"Guident","F":"福特汽车","NGD":"New Gold"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2144742524","content_text":"Ford joined General Motors with upbeat earnings guidance and sees strong reservations for critical new vehicles including its first electric truck. Ford stock rose.\nThe No. 2 U.S. auto giant said Thursday that it expects adjusted pretax earnings for the second quarter to surpass its own expectations and be \"significantly better\" than a year ago.\nThat's despite the semiconductor shortage, which Ford said April 28 would halve its planned Q2 production and reduce full-year adjusted EBIT to $5.5 billion-$6.5 billion.\nFord did not offer specific Q2 guidance on April 28 or Thursday. It will report for Q2 and offer outlook for the rest of the year July 28.\nOn Wednesday, GM forecast adjusted earnings before taxes of $8.5 billion-$9.5 billion in the first half of 2021, up from an earlier view for $5.5 billion, due to strong demand for its SUVs and trucks. GM remains cautious for the full year.\nAlso Thursday, Ford touted 100,000 reservations for the F-150 Lightning, its first all-electric pickup truck and Tesla Cybertruck rival. That's up from 20,000 reported May 20 after a launch event, and 70,000 on May 26.\nMeanwhile, its new compact Maverick truck has 36,000 reservations, just a week after unveiling. Ford also reported 20,000 reservations for the all-electric E-Transit commercial van and 190,000 for the new, full-size Bronco SUV.\nCEO Jim Farley will further address Q2 financial guidance at a Deutsche Bank auto industry conference Thursday afternoon.\nFord Stock\nShares rose 1.3% to 15.22 in Thursday's stock market. Ford stock, on the IBD Leaderboard, is extended from a cup-without-handle 13.72 buy point, cleared late May on its bold EV shift. GM stock eased 1% to 61.07 as it eyes a 63.54 cup-shaped buy point.\nOn Wednesday, GM announced it will invest $35 billion to develop electric vehicles (EVs) and autonomous vehicles (AVs) through 2025. That's a 30% increase from its most recent forecast for $27 billion set last November, and a 75% increase from an initial forecast of $20 billion set in March 2020.\nBy comparison, Ford in May announced $30 billion on EV- AV spending through 2025, up from a prior view for $22 billion.\nBut Ford's investments include years prior to 2020, while GM's spending is for 2020 through 2025.","news_type":1,"symbols_score_info":{"GUID":0.9,"F":0.9,"NGD":0.9}},"isVote":1,"tweetType":1,"viewCount":2570,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}